| Literature DB >> 30283352 |
Hua Zou1, Ce Xi2, Xiaodan Zhao1, Angela S Koh1,3, Fei Gao1, Yi Su4, Ru-San Tan1,3, John Allen3, Lik Chuan Lee2, Martin Genet5,6, Liang Zhong1,3.
Abstract
Heart failure (HF) imposes a major global health care burden on society and suffering on the individual. About 50% of HF patients have preserved ejection fraction (HFpEF). More intricate and comprehensive measurement-focused imaging of multiple strain components may aid in the diagnosis and elucidation of this disease. Here, we describe the development of a semi-automated hyperelastic warping method for rapid comprehensive assessment of biventricular circumferential, longitudinal, and radial strains that is physiological meaningful and reproducible. We recruited and performed cardiac magnetic resonance (CMR) imaging on 30 subjects [10 HFpEF, 10 HF with reduced ejection fraction patients (HFrEF) and 10 healthy controls]. In each subject, a three-dimensional heart model including left ventricle (LV), right ventricle (RV), and septum was reconstructed from CMR images. The hyperelastic warping method was used to reference the segmented model with the target images and biventricular circumferential, longitudinal, and radial strain-time curves were obtained. The peak systolic strains are then measured and analyzed in this study. Intra- and inter-observer reproducibility of the biventricular peak systolic strains was excellent with all ICCs > 0.92. LV peak systolic circumferential, longitudinal, and radial strain, respectively, exhibited a progressive decrease in magnitude from healthy control→HFpEF→HFrEF: control (-15.5 ± 1.90, -15.6 ± 2.06, 41.4 ± 12.2%); HFpEF (-9.37 ± 3.23, -11.3 ± 1.76, 22.8 ± 13.1%); HFrEF (-4.75 ± 2.74, -7.55 ± 1.75, 10.8 ± 4.61%). A similar progressive decrease in magnitude was observed for RV peak systolic circumferential, longitudinal and radial strain: control (-9.91 ± 2.25, -14.5 ± 2.63, 26.8 ± 7.16%); HFpEF (-7.38 ± 3.17, -12.0 ± 2.45, 21.5 ± 10.0%); HFrEF (-5.92 ± 3.13, -8.63 ± 2.79, 15.2 ± 6.33%). Furthermore, septum peak systolic circumferential, longitudinal, and radial strain magnitude decreased gradually from healthy control to HFrEF: control (-7.11 ± 1.81, 16.3 ± 3.23, 18.5 ± 8.64%); HFpEF (-6.11 ± 3.98, -13.4 ± 3.02, 12.5 ± 6.38%); HFrEF (-1.42 ± 1.36, -8.99 ± 2.96, 3.35 ± 2.95%). The ROC analysis indicated LV peak systolic circumferential strain to be the most sensitive marker for differentiating HFpEF from healthy controls. Our results suggest that the hyperelastic warping method with the CMR-derived strains may reveal subtle impairment in HF biventricular mechanics, in particular despite a "normal" ventricular ejection fraction in HFpEF.Entities:
Keywords: heart failure with preserved ejection fraction; hyperelastic warping; left ventricle; right ventricle; strain
Year: 2018 PMID: 30283352 PMCID: PMC6156386 DOI: 10.3389/fphys.2018.01295
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Demographics of study populations.
| Characteristics | Normal (n = 10) | HFpEF (n = 10) | HFrEF (n = 10) | HFpEF |
|---|---|---|---|---|
| Age (year) | 52.1 ± 12.7 | 52.4 ± 12.5 | 52.7 ± 11.6 | NS |
| Gender (F/M) | 2/8 | 2/8 | 2/8 | NS |
| Height (cm) | 167.9 ± 8.6 | 164.1 ± 7.4 | 167.3 ± 10.8 | NS |
| Weight (kg) | 69.7 ± 11.4 | 76.5 ± 16.7 | 86.2 ± 22.2* | NS |
| BSA (m2) | 1.79 ± 0.18 | 1.85 ± 0.23 | 1.97 ± 0.30 | NS |
| SBP (mmHg) | 133.7 ± 11.6 | 136.1 ± 34.1 | 124.2 ± 19.6 | NS |
| DBP(mmHg) | 81 ± 9.37 | 75.7 ± 25.8 | 71.9 ± 13.1 | NS |
| LVEF (%) | 65 ± 6 | 53 ± 7* | 25 ± 9* | <0.05 |
| LVEDV index (ml/m2) | 71.0 ± 12.8 | 89.7 ± 17.0* | 148.3 ± 53.1* | <0.05 |
| LVESV index (ml/m2) | 25.0 ± 6.6 | 43.1 ± 13.2* | 114.0 ± 50.0* | <0.05 |
| LVSV index (ml/m2) | 46.1 ± 8.7 | 46.7 ± 7.4 | 34.3 ± 13.1 | 0.053 |
| LV mass index (g/m2) | 47.8 ± 6.6 | 69.1 ± 19.5* | 79.3 ± 27.2* | NS |
| RVEF (%) | 56 ± 6 | 57 ± 7 | 40 ± 12* | <0.05 |
| RVEDV index (ml/m2) | 79.5 ± 15.2 | 76.1 ± 16.7 | 89.6 ± 29.9 | NS |
| RVESV index (ml/m2) | 35.7 ± 9.4 | 33.1 ± 9.6 | 54.8 ± 26.3* | <0.05 |
| RVSV index (g/m2) | 43.7 ± 7.2 | 43.3 ± 9.7 | 34.7 ± 13.3 | NS |
| Pulse (BPM) | 72 ± 10 | 58 ± 10 | 83 ± 24 | <0.05 |
| NYHA (I), | N.A | 3 (30) | 4 (30) | NS |
| NYHA (II), | N.A | 5 (50) | 4 (30) | NS |
| NYHA (III), | N.A | 1 (10) | 2 (20) | NS |
| NYHA (IV), | N.A | 1 (10) | 0 (0) | NS |
| Atrial flutter/fibrillation, | N.A | 2 (20) | 1 (10) | NS |
| Cancer within last five years, | N.A | 0 (0) | 0 (0) | NS |
| Chronic renal insufficiency, | N.A | 2 (20) | 0 (0) | NS |
| Current smoker, | N.A | 4 (40) | 1 (10) | NS |
| Depression, | N.A | 0 (0) | 0 (0) | NS |
| Diabetes, | N.A | 3 (30) | 6 (60) | NS |
| Hyperlipidemia, | N.A | 7 (70) | 5 (50) | NS |
| Hypertension, | N.A | 8 (80) | 5 (50) | NS |
| Peripheral vascular disease, n (%) | N.A | 1 (10) | 0 (0) | NS |
| Myocardial infarction, | N.A | 1 (10) | 0 (0) | NS |
| Stroke, | N.A | 0 (0) | 1 (10) | NS |
| NTproBNP | N.A | 2667.2 ± 2519.6 | 921.6 ± 837.7 | <0.05 |
Average circumferential, longitudinal, and radial strains for RV, LV, and septum.
| Strain parameters | Normal | HFpEF | HFrEF | HFpEF vs. HFrEF§ |
|---|---|---|---|---|
| -9.91 ± 2.25 | -7.38 ± 3.17 | -5.92 ± 3.13* | NS | |
| -15.49 ± 1.90 | -9.37 ± 3.23* | -4.75 ± 2.74* | <0.05 | |
| -7.11 ± 1.81 | -6.11 ± 3.98* | -1.42 ± 1.36* | <0.05 | |
| -14.49 ± 2.63 | -12.04 ± 2.45* | -8.63 ± 2.79* | <0.05 | |
| -15.58 ± 2.06 | -11.30 ± 1.76* | -7.55 ± 1.75* | <0.05 | |
| -16.26 ± 3.23 | -13.38 ± 3.02* | -8.89 ± 2.96* | <0.05 | |
| 26.79 ± 7.16 | 21.49 ± 10.01 | 15.15 ± 6.33* | NS | |
| 41.41 ± 12.20 | 22.81 ± 13.05* | 10.84 ± 4.61* | <0.05 | |
| 18.51 ± 8.64 | 12.45 ± 6.38 | 3.35 ± 2.95* | <0.05 | |
Sensitivity, specificity and AUC of the strains and LVEF for differentiating normal controls and HFpEF.
| Parameters | Patient type | Cut-off value | Sensitivity | Specificity | AUC |
|---|---|---|---|---|---|
| HFpEF | 6.39 | 0.400 | 1.000 | 0.715 | |
| HFpEF | 13.10 | 1.000 | 1.000 | 1.000 | |
| HFpEF | 7.26 | 0.800 | 0.700 | 0.690 | |
| HFpEF | 14.12 | 0.800 | 0.800 | 0.780 | |
| HFpEF | 12.85 | 0.900 | 0.900 | 0.950 | |
| HFpEF | 14.90 | 0.700 | 0.900 | 0.750 | |
| HFpEF | 25.26 | 0.700 | 0.600 | 0.660 | |
| HFpEF | 30.53 | 0.900 | 0.800 | 0.890 | |
| HFpEF | 20.51 | 0.900 | 0.500 | 0.700 | |
| LVEF | HFpEF | 59 | 0.800 | 1.000 | 0.945 |
Inter- and intra-observer agreement for nine randomly chosen cases (three control, three HFpEF, and three HFrEF).
| Variable | Variability | Mean bias ± | Limits of agreement | Coefficient of variation (%) | ICC (95% CI) |
|---|---|---|---|---|---|
| Intra-observer | 0.20 ± 1.31 | -2.38 to 2.78 | 10.40 | 0.954 (0.799, 0.990) | |
| Inter-observer | 1.00 ± 1.24 | -1.43 to 3.43 | 11.89 | 0.964 (0.839, 0.992) | |
| Intra-observer | 0.08 ± 0.63 | -1.16 to 1.32 | 4.18 | 0.997 (0.988, 0.999) | |
| Inter-observer | 0.67 ± 0.90 | -1.10 to 2.45 | 7.27 | 0.994 (0.973, 0.999) | |
| Intra-observer | 0.56 ± 0.51 | -0.45 to 1.58 | 11.27 | 0.989 (0.843, 0.998) | |
| Inter-observer | 0.55 ± 1.73 | -2.85 to 3.95 | 23.35 | 0.952 (0.787, 0.989) | |
| Intra-observer | -0.91 ± 1.56 | -3.97 to 2.15 | 9.30 | 0.940 (0.728, 0.987) | |
| Inter-observer | -0.27 ± 1.57 | -3.35 to 2.81 | 8.48 | 0.945 (0.758, 0.988) | |
| Intra-observer | -0.54 ± 0.86 | -2.23 to 1.14 | 5.77 | 0.989 (0.944, 0.998) | |
| Inter-observer | -0.56 ± 1.42 | -3.35 to 2.23 | 8.98 | 0.974 (0.883, 0.994) | |
| Intra-observer | -1.23 ± 1.35 | -3.89 to 1.42 | 9.11 | 0.963 (0.692, 0.993) | |
| Inter-observer | -1.32 ± 2.38 | -6.00 to 3.35 | 14.78 | 0.921 (0.649, 0.982) | |
| Intra-observer | 1.28 ± 4.23 | -7.01 to 9.57 | 12.41 | 0.953 (0.805, 0.989) | |
| Inter-observer | 4.97 ± 3.52 | -1.94 to 11.88 | 20.39 | 0.953 (0.794, 0.990) | |
| Intra-observer | 0.47 ± 2.47 | -4.36 to 5.31 | 6.15 | 0.997 (0.987, 0.999) | |
| Inter-observer | 5.63 ± 8.30 | -10.63 to 21.90 | 28.09 | 0.948 (0.769, 0.988) | |
| Intra-observer | -0.87 ± 1.12 | -3.06 to 1.31 | 8.74 | 0.995 (0.965, 0.999) | |
| Inter-observer | 1.00 ± 2.29 | -3.49 to 5.50 | 15.33 | 0.986 (0.939, 0.977) | |